Hightide Therapeutics Inc (HK:2511) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
HighTide Therapeutics Inc. has announced a change of auditor, appointing Moore CPA Limited after Ernst & Young resigned over a fee disagreement. The company believes this move will enhance cost-effectiveness without impacting the annual audit process. The decision was made with the Audit Committee’s recommendation, considering Moore HK’s competence and market reputation.
For further insights into HK:2511 stock, check out TipRanks’ Stock Analysis page.